MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
Healthcare
$16.99 +2.63%
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
52W Low $10.65High $20.48
Volume 4.70M
Average 0.95M
Income Statement
Follow revenue through to earnings.
Revenue
$3.10B
FY 2025 · Annual
+14.3% YoYOperating Income
$49.00M
FY 2025 · Annual
Net Income
-$331.00M
FY 2025 · Annual
Income Statement
USD
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Revenue | 2.25B | 2.47B | 2.72B | 3.1B |
| Cost of Revenue | 937M | 1.03B | 1.19B | 1.42B |
| Gross Profit | 1.31B | 1.44B | 1.53B | 1.68B |
| Gross Margin | 58.3% | 58.2% | 56.2% | 54.2% |
| Research & Development | 429M | 437M | 438M | 448M |
| Selling, General & Admin | 960M | 1.06B | 1.13B | 1.18B |
| Operating Expenses | 1.38B | 1.51B | 1.73B | 1.63B |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| EBITDA | 39M | 59M | 107M | 205M |
| EBITDA Margin | 1.7% | 2.4% | 3.9% | 6.6% |
| Operating Income | (69M) | (69M) | (202M) | 49M |
| Operating Margin | -3.1% | -2.8% | -7.4% | 1.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (7M) | (1M) | (1M) | (236M) |
| Income Before Tax | (76M) | (70M) | (203M) | (187M) |
| Pre-Tax Margin | -3.4% | -2.8% | -7.5% | -6.0% |
| Income Tax Expense | 16M | 38M | 48M | 128M |
| Net Income | (96M) | (112M) | (250M) | (331M) |
| Net Margin | -4.3% | -4.5% | -9.2% | -10.7% |
| EPS (Basic) | (0.34) | (0.40) | (0.89) | (1.29) |
| EPS (Diluted) | (0.34) | (0.40) | (0.89) | (1.29) |
| 280.81M | 280.81M | 280.81M | 256.6M | |
| 280.81M | 280.81M | 280.81M | 256.6M |
MMED Earnings Waterfall · TTM
NASDAQ:MMED · Revenue to Net Income
Key Ratios
EPS$-1.10
Gross Margin53.8%
Net Margin-10.1%
P/E Ratio-4.0
P/S Ratio4.2
Analysis
$3.2B of revenue converted into -$329.0M of net income for the selected period. Gross margin is 53.8% and net margin is -10.1%, showing how much revenue survives after costs and taxes. EPS is $-1.10, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| SC 13G | SC 13G filing | Oct 22, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 19, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 19, 2026 |
How much revenue does MMED generate?
MiniMed Group, Inc. Common Stock (MMED) reported $3.10B of revenue in fiscal 2025.
Is MMED profitable?
MiniMed Group, Inc. Common Stock (MMED) reported -$331.00M of net income, with a net margin of -10.7%.
Continue the stock analysis
Jump to another research area for this company.